Image guided evaluation of 212Pb-VMT-a-NET in metastatic Neuroendocrine tumors: Bio distribution and Dosimetry

被引：0
|
作者：
Malik, D. [1 ]
Thakral, P. [1 ]
Rana, N. [1 ]
Singh, N. [1 ]
Koley, M. [1 ]
Gupta, J. [1 ]
Thakrani, D. [1 ]
Kapoor, S. [2 ]
Das, S. S. [1 ]
Schultz, M. [2 ]
Sen, I. [1 ]
机构：
[1] Fortis Mem Res Inst FMRI, Gurugram, India
[2] Perspect Therapeut, Iowa City, IA USA
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0929
引用
收藏
页码：S803 / S804
页数：2
相关论文
共 24 条
  • [1] Charting the Course of Targeted α Therapy With First-in-Human, Postadministration Image-Guided Dosimetry and Response Assessment of 212Pb-VMT-α-NET in Metastatic Neuroendocrine Tumors
    Singh, Navneet
    Rana, Nishant
    Thakral, Parul
    Malik, Dharmender
    Schultz, Michael K.
    Sen, Ishita B.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : 546 - 548
  • [2] Initial Results of Image guided dosimetry of 212Pb-VMT-I±-peptide
    Thakral, Parul
    Rana, Nishant
    Singh, Navneet
    Khichi, Deepak
    Koley, Mrinalini
    Das, Subha
    Malik, Dharmender
    Sen, Ishita
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [3] Interim results of 212Pb-VMT-a-NET Targeted Alpha Therapy in Metastatic Gastro-entero-pancreatic Neuroendocrine Tumors: First In-human Clinical Results on Safety and Efficacy
    Malik, D.
    Sen, I.
    Thakral, P.
    Das, S. S.
    Kapoor, S.
    Kumari, J.
    Singh, N.
    Rana, N.
    Koley, M.
    Gupta, J.
    Thakrani, D.
    Schultz, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S124 - S124
  • [4] 212Pb-VMT-I±-NET Targeted Alpha Therapy in Metastatic Neuroendocrine Tumors: First in Human study on Safety and Efficacy
    Sen, Ishita
    Malik, Dharmender
    Thakral, Parul
    Schultz, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [5] First-in-human SPECT/CT imaging of [212Pb]Pb-VMT-α-NET in a patient with metastatic neuroendocrine tumor
    Enrico Michler
    David Kästner
    Claudia Brogsitter
    Marc Pretze
    Holger Hartmann
    Robert Freudenberg
    Michael K. Schultz
    Jörg Kotzerke
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1490 - 1492
  • [6] First-in-human SPECT/CT imaging of [212Pb]Pb-VMT-α-NET in a patient with metastatic neuroendocrine tumor
    Michler, Enrico
    Kaestner, David
    Brogsitter, Claudia
    Pretze, Marc
    Hartmann, Holger
    Freudenberg, Robert
    Schultz, Michael K.
    Kotzerke, Joerg
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (05) : 1490 - 1492
  • [7] Evaluation of renal and hematologic toxicities of 212Pb-VMT-alpha-NET to inform the safety of alpha-particle therapy for neuroendocrine tumors
    Lee, D.
    Li, M.
    Liu, D.
    Baumhover, N.
    Sagastume, E. A.
    Marks, B.
    Graves, S. A.
    Zepeda-Orozco, D.
    Johnson, F. L.
    Menda, Y.
    Bushnell, D. L.
    Schultz, M. K.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 190 - 190
  • [8] Targeted alpha therapy of [212Pb]VMT-α-NET in metastatic neuroblastoma model
    Liu, Dijie
    Dai, Zhiming
    Ewald, Jordan
    Cagle, Brianna
    Li, Mengshi
    Hanna, Alaa
    Sagastume, Edwin
    Robles-Planells, Claudia
    Rodman, Samuel
    Johnson, Frances
    Zepeda-Orozco, Diana
    Schultz, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [9] Preclinical Evaluation of [212Pb]VMT-α-NET Targeted Alpha Therapy for High-Risk Metastatic Neuroblastoma
    Liu, D.
    Ewald, J. T.
    Dai, Z.
    Robels-Plannels, C.
    Cagle, B. S.
    Rodman, S. N., III
    Li, M.
    Rastogi, R.
    Sagastume, E.
    Johnson, F. L.
    Zepeda-Orozco, D.
    Schultz, M. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S65 - S65
  • [10] Early results of 212Pb-VMT-α-NET Targeted Alpha Therapy in Metastatic Gastro-entero-pancreatic Neuroendocrine Tumors: First in Human Clinical Experience on Safety and Efficacy
    Malik, D.
    Sen, I.
    Thakral, P.
    Das, S.
    Schultz, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S313 - S313
123